| Oxidative stress in type 2 diabetes: impacts from pathogenesis to lifestyle modifications A Caturano, M D’Angelo, A Mormone, V Russo, MP Mollica, T Salvatore, ... Current Issues in Molecular Biology 45 (8), 6651-6666, 2023 | 194 | 2023 |
| The Importance of Telemedicine during COVID‐19 Pandemic: A Focus on Diabetic Retinopathy R Galiero, PC Pafundi, R Nevola, L Rinaldi, C Acierno, A Caturano, ... Journal of diabetes research 2020 (1), 9036847, 2020 | 189 | 2020 |
| An overview of the cardiorenal protective mechanisms of SGLT2 inhibitors T Salvatore, R Galiero, A Caturano, L Rinaldi, A Di Martino, G Albanese, ... International Journal of Molecular Sciences 23 (7), 3651, 2022 | 172 | 2022 |
| Mechanisms of non-alcoholic fatty liver disease in the metabolic syndrome. A narrative review L Rinaldi, PC Pafundi, R Galiero, A Caturano, MV Morone, C Silvestri, ... Antioxidants 10 (2), 270, 2021 | 153 | 2021 |
| Efficacy and durability of multifactorial intervention on mortality and MACEs: A randomized clinical trial in type-2 diabetic kidney disease FC Sasso, PC Pafundi, V Simeon, L De Nicola, P Chiodini, R Galiero, ... Cardiovascular Diabetology 20, 1-12, 2021 | 125 | 2021 |
| The diabetic cardiomyopathy: the contributing pathophysiological mechanisms T Salvatore, PC Pafundi, R Galiero, G Albanese, A Di Martino, A Caturano, ... Frontiers in Medicine 8, 695792, 2021 | 123 | 2021 |
| Peripheral neuropathy in diabetes mellitus: pathogenetic mechanisms and diagnostic options R Galiero, A Caturano, E Vetrano, D Beccia, C Brin, M Alfano, J Di Salvo, ... International Journal of Molecular Sciences 24 (4), 3554, 2023 | 96 | 2023 |
| Can metformin exert as an active drug on endothelial dysfunction in diabetic subjects? T Salvatore, PC Pafundi, R Galiero, L Rinaldi, A Caturano, E Vetrano, ... Biomedicines 9 (1), 3, 2020 | 95 | 2020 |
| Impact of SGLT2 inhibitors on heart failure: from pathophysiology to clinical effects G Palmiero, A Cesaro, E Vetrano, PC Pafundi, R Galiero, A Caturano, ... International Journal of Molecular Sciences 22 (11), 5863, 2021 | 94 | 2021 |
| Non-alcoholic fatty liver disease: From pathogenesis to clinical impact A Caturano, C Acierno, R Nevola, PC Pafundi, R Galiero, L Rinaldi, ... Processes 9 (1), 135, 2021 | 82 | 2021 |
| Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease R Galiero, A Caturano, E Vetrano, A Cesaro, L Rinaldi, T Salvatore, ... Reviews in cardiovascular medicine 22 (3), 755-768, 2021 | 80 | 2021 |
| Effects of metformin in heart failure: from pathophysiological rationale to clinical evidence T Salvatore, R Galiero, A Caturano, E Vetrano, L Rinaldi, F Coviello, ... Biomolecules 11 (12), 1834, 2021 | 77 | 2021 |
| Cardiovascular benefits from gliflozins: effects on endothelial function T Salvatore, A Caturano, R Galiero, A Di Martino, G Albanese, E Vetrano, ... Biomedicines 9 (10), 1356, 2021 | 72 | 2021 |
| Does a strict glycemic control during acute coronary syndrome play a cardioprotective effect? Pathophysiology and clinical evidence A Caturano, R Galiero, PC Pafundi, A Cesaro, E Vetrano, G Palmiero, ... Diabetes research and clinical practice 178, 108959, 2021 | 67 | 2021 |
| The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc … FC Sasso, V Simeon, R Galiero, A Caturano, L De Nicola, P Chiodini, ... Cardiovascular Diabetology 21 (1), 235, 2022 | 66 | 2022 |
| Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study R Galiero, PC Pafundi, V Simeon, L Rinaldi, A Perrella, E Vetrano, ... PloS one 15 (12), e0243700, 2020 | 56 | 2020 |
| High HDL cholesterol: A risk factor for diabetic retinopathy? Findings from NO BLIND study FC Sasso, PC Pafundi, A Gelso, V Bono, C Costagliola, R Marfella, ... Diabetes research and clinical practice 150, 236-244, 2019 | 55 | 2019 |
| Coronary microvascular dysfunction in diabetes mellitus: pathogenetic mechanisms and potential therapeutic options T Salvatore, R Galiero, A Caturano, E Vetrano, G Loffredo, L Rinaldi, ... Biomedicines 10 (9), 2274, 2022 | 53 | 2022 |
| Nonalcoholic fatty liver disease and type 2 diabetes: pathophysiological mechanisms shared between the two faces of the same coin C Acierno, A Caturano, PC Pafundi, R Nevola, LE Adinolfi, FC Sasso Explor Med. 2020 1 (1), 287-306, 2020 | 53 | 2020 |
| Relationship between albuminuric CKD and diabetic retinopathy in a real-world setting of type 2 diabetes: Findings from No blind study FC Sasso, PC Pafundi, A Gelso, V Bono, C Costagliola, R Marfella, ... Nutrition, Metabolism and Cardiovascular Diseases 29 (9), 923-930, 2019 | 51 | 2019 |
